Rezolute, Inc.
NASDAQRezolute, Inc. heads into tonight's earnings release with short sellers adding pressure just as the company's lead drug candidate faces its most consequential test. Short interest is the dominant signal here. It has climbed to 15.1% of the free float — up 11.6% on the week and 8% in a single session on May 11 — after spending most of April on a steady decline from a peak near 22%…
Snapshot as of 25 Jun 2026
Rezolute, Inc. heads into tonight's earnings release with short sellers adding pressure just as the company's lead drug candidate faces its most consequential test. Short interest is the dominant signal here. It has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RZLT — free to start on ORTEX.
Sign up for free →Open RZLT on ORTEX